A controlled trial of photochemotherapy for persistent palmoplantar pustulosis. 1980

D Murray, and M F Corbett, and A P Warin

Twenty-two patients with bilaterally symmetrical persistent palmoplantar pustulosis were treated on one randomly selected side with oral psoralen and long-wave ultraviolet light. The treated side cleared completely in twelve patients, almost cleared in five patients and improved in four. One patient improved on both sides. Fifteen of the twenty-two patients were then treated with topical psoralen and long-wave ultraviolet light on the side that had previously been used as a control. Similar results were obtained. Seven patients cleared completely, six patients were much improved and two were improved. These results are significantly different from those liable to occur by chance (P < 0.001).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010778 Photochemotherapy Therapy using oral or topical photosensitizing agents with subsequent exposure to light. Blue Light Photodynamic Therapy,Photodynamic Therapy,Red Light PDT,Red Light Photodynamic Therapy,Therapy, Photodynamic,Light PDT, Red,PDT, Red Light,Photochemotherapies,Photodynamic Therapies,Therapies, Photodynamic
D011701 PUVA Therapy Photochemotherapy using PSORALENS as the photosensitizing agent and ultraviolet light type A (UVA). Psoralen Ultraviolet A Therapy,Therapy, PUVA,PUVA Therapies,Therapies, PUVA
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D005533 Foot Dermatoses Skin diseases of the foot, general or unspecified. Foot Dermatosis,Dermatoses, Foot,Dermatosis, Foot
D006229 Hand Dermatoses Skin diseases involving the HANDS. Hand Dermatosis,Dermatoses, Hand,Dermatosis, Hand
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D Murray, and M F Corbett, and A P Warin
July 1979, The British journal of dermatology,
D Murray, and M F Corbett, and A P Warin
June 1991, The British journal of dermatology,
D Murray, and M F Corbett, and A P Warin
September 1976, The British journal of dermatology,
D Murray, and M F Corbett, and A P Warin
January 1979, Acta dermato-venereologica. Supplementum,
D Murray, and M F Corbett, and A P Warin
May 2023, JAAD case reports,
D Murray, and M F Corbett, and A P Warin
January 2014, The Pan African medical journal,
D Murray, and M F Corbett, and A P Warin
April 1992, Journal of autoimmunity,
D Murray, and M F Corbett, and A P Warin
January 1983, Dermatologica,
D Murray, and M F Corbett, and A P Warin
August 2013, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
D Murray, and M F Corbett, and A P Warin
January 1979, Duodecim; laaketieteellinen aikakauskirja,
Copied contents to your clipboard!